{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:11:49Z","timestamp":1758636709328,"version":"3.40.2"},"reference-count":25,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,3,18]]},"DOI":"10.1248\/bpb.b24-00730","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T22:13:46Z","timestamp":1742249626000},"page":"262-266","source":"Crossref","is-referenced-by-count":2,"title":["RasGRP2 Attenuates TAGE Modification of eNOS in Vascular Endothelial Cells"],"prefix":"10.1248","volume":"48","author":[{"given":"Shouhei","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hiroshima International University, 5\u20131\u20131 Hirokoshingai, Kure, Hiroshima 737\u20130112, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Takino","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hiroshima International University, 5\u20131\u20131 Hirokoshingai, Kure, Hiroshima 737\u20130112, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Nagamine","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hiroshima International University, 5\u20131\u20131 Hirokoshingai, Kure, Hiroshima 737\u20130112, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1\u20131 Daigaku, Uchinada-machi, Kahoku, Ishikawa 920\u20130293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamitsu","family":"Hori","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hiroshima International University, 5\u20131\u20131 Hirokoshingai, Kure, Hiroshima 737\u20130112, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sakai-Sakasai A, Takeda K, Suzuki H, Takeuchi M. Structures of toxic advanced glycation end-products derived from glyceraldehyde, a sugar metabolite. <i>Biomolecules<\/i>, <b>14<\/b>, 202 (2024).","DOI":"10.3390\/biom14020202"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Takeuchi M, Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. <i>Med. Hypotheses.<\/i>, <b>63<\/b>, 449\u2013452 (2004).","DOI":"10.1016\/j.mehy.2004.02.042"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Takeuchi M, Sakasai-Sakai A, Takata T, Takino JI, Koriyama Y. Effects of toxic AGEs (TAGE) on human health. <i>Cells<\/i>, <b>11<\/b>, 2178 (2022).","DOI":"10.3390\/cells11142178"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sakasai-Sakai A, Takata T, Takino JI, Takeuchi M. The relevance of toxic AGEs (TAGE) cytotoxicity to NASH pathogenesis: a mini-review. <i>Nutrients<\/i>, <b>11<\/b>, 462 (2019).","DOI":"10.3390\/nu11020462"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ooi H, Koriyama Y. Toxic advanced glycation end-products-dependent Alzheimer\u2019s disease-like alternation in the microtubule system. <i>Curr. Alzheimer Res.<\/i>, <b>20<\/b>, 677\u2013681 (2023).","DOI":"10.2174\/0115672050288723240213053342"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lundberg JO, Weitzberg E. Nitric oxide signaling in health and disease. <i>Cell<\/i>, <b>185<\/b>, 2853\u20132878 (2022).","DOI":"10.1016\/j.cell.2022.06.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric oxide and endothelial dysfunction. <i>Crit. Care Clin<\/i>., <b>36<\/b>, 307\u2013321 (2020).","DOI":"10.1016\/j.ccc.2019.12.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Luo S, Lei H, Qin H, Xia Y. Molecular mechanisms of endothelial NO synthase uncoupling. <i>Curr. Pharm. Des.<\/i>, <b>20<\/b>, 3548\u20133553 (2014).","DOI":"10.2174\/13816128113196660746"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yoon HJ, Cho SW, Ahn BW, Yang SY. Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. <i>Mech. Ageing Dev.<\/i>, <b>131<\/b>, 119\u2013123 (2010).","DOI":"10.1016\/j.mad.2009.12.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Won D, Zhu SN, Chen M, Teichert AM, Fish JE, Matouk CC, Bonert M, Ojha M, Marsden PA, Cybulsky MI. Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an <i>in vitro<\/i> model of disturbed flow. <i>Am. J. Pathol.<\/i>, <b>171<\/b>, 1691\u20131704 (2007).","DOI":"10.2353\/ajpath.2007.060860"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. <i>Circulation<\/i>, <b>105<\/b>, 1656\u20131662 (2002).","DOI":"10.1161\/01.CIR.0000012748.58444.08"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nagamine K, Matsuda A, Hori T. Identification of the gene regulatory region in human rasgrp2 gene in vascular endothelial cells. <i>Biol. Pharm. Bull.<\/i>, <b>33<\/b>, 1138\u20131142 (2010).","DOI":"10.1248\/bpb.33.1138"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sato T, Takino JI, Nagamine K, Nishio K, Hori T. RASGRP2 Suppresses Apoptosis <i>via<\/i> Inhibition of ROS Production in Vascular Endothelial Cells. <i>Scientific World Journal<\/i>, <b>2019<\/b>, 4639165.","DOI":"10.1155\/2019\/4639165"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takino JI, Sato T, Nagamine K, Hori T. The inhibition of Bax activation-induced apoptosis by RasGRP2 <i>via<\/i> R-Ras-PI3K-Akt signaling pathway in the endothelial cells. <i>Sci. Rep.<\/i>, <b>9<\/b>, 16717 (2019).","DOI":"10.1038\/s41598-019-53419-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takino JI, Sato T, Kanetaka T, Okihara K, Nagamine K, Takeuchi M, Hori T. RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells. <i>Sci. Rep.<\/i>, <b>11<\/b>, 2959 (2021).","DOI":"10.1038\/s41598-021-82619-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takata T, Murayama H, Masauji T. Slot blot analysis of intracellular glyceraldehyde-derived advanced glycation end products using a novel lysis buffer and polyvinylidene difluoride membrane. <i>Bio Protoc.<\/i>, <b>14<\/b>, e5038 (2024).","DOI":"10.21769\/BioProtoc.5038"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds <i>in vivo<\/i>. <i>Mol. Med.<\/i>, <b>6<\/b>, 114\u2013125 (2000).","DOI":"10.1007\/BF03401779"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. <i>Arch. Biochem. Biophys.<\/i>, <b>419<\/b>, 31\u201340 (2003).","DOI":"10.1016\/j.abb.2003.08.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sakasai-Sakai A, Takata T, Takino JI, Takeuchi M. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. <i>Sci. Rep.<\/i>, <b>7<\/b>, 14282 (2017).","DOI":"10.1038\/s41598-017-14711-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. <i>Diabetes<\/i>, <b>41<\/b>, 26\u201329 (1992).","DOI":"10.2337\/diabetes.41.1.26"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nowotny K, Jung T, H\u00f6hn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. <i>Biomolecules<\/i>, <b>5<\/b>, 194\u2013222 (2015).","DOI":"10.3390\/biom5010194"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Venema RC, Sayegh HS, Kent JD, Harrison DG. Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. <i>J. Biol. Chem.<\/i>, <b>271<\/b>, 6435\u20136440 (1996).","DOI":"10.1074\/jbc.271.11.6435"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Heiss EH, Dirsch VM. Regulation of eNOS enzyme activity by posttranslational modification. <i>Curr. Pharm. Des.<\/i>, <b>20<\/b>, 3503\u20133513 (2014).","DOI":"10.2174\/13816128113196660745"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. <i>Circ. Res.<\/i>, <b>88<\/b>, E14\u2013E22 (2001).","DOI":"10.1161\/01.RES.88.2.e14"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Muller G, Morawietz H. Nitric oxide, NAD(P)H oxidase, and atherosclerosis. <i>Antioxid. Redox Signal<\/i>, <b>11<\/b>, 17111731 (2009).","DOI":"10.1089\/ars.2008.2403"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/3\/48_b24-00730\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T08:40:20Z","timestamp":1742719220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/3\/48_b24-00730\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00730","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"b24-00730"}}